These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. Sieper J, Klopsch T, Richter M, Kapelle A, Rudwaleit M, Schwank S, Regourd E, May M. Ann Rheum Dis; 2008 Mar; 67(3):323-9. PubMed ID: 17616556 [Abstract] [Full Text] [Related]
3. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Singh G, Fort JG, Goldstein JL, Levy RA, Hanrahan PS, Bello AE, Andrade-Ortega L, Wallemark C, Agrawal NM, Eisen GM, Stenson WF, Triadafilopoulos G, SUCCESS-I Investigators. Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472 [Abstract] [Full Text] [Related]
4. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, Verburg KM, Isakson PC, Hubbard RC, Geis GS. Lancet; 2006 Mar; 354(9196):2106-11. PubMed ID: 10609815 [Abstract] [Full Text] [Related]
5. Celecoxib is as efficacious as naproxen in the management of acute shoulder pain. Bertin P, Béhier JM, Noël E, Leroux JL. J Int Med Res; 2003 Mar; 31(2):102-12. PubMed ID: 12760313 [Abstract] [Full Text] [Related]
6. Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial. Kellner HL, Li C, Essex MN. Curr Med Res Opin; 2012 Sep; 28(9):1537-45. PubMed ID: 22852870 [Abstract] [Full Text] [Related]
7. Valdecoxib is as effective as diclofenac in the management of rheumatoid arthritis with a lower incidence of gastroduodenal ulcers: results of a 26-week trial. Pavelka K, Recker DP, Verburg KM. Rheumatology (Oxford); 2003 Oct; 42(10):1207-15. PubMed ID: 12810937 [Abstract] [Full Text] [Related]
9. Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population. Nadarajah A, Abrahan L, Lau FL, Hwang LJ, Fakir-Bolte C. Singapore Med J; 2006 Jun; 47(6):534-42. PubMed ID: 16752024 [Abstract] [Full Text] [Related]
10. A randomized, multicentre, double-blind, parallel-group study to assess the adverse event-related discontinuation rate with celecoxib and diclofenac in elderly patients with osteoarthritis. Dahlberg LE, Holme I, Høye K, Ringertz B. Scand J Rheumatol; 2009 Jun; 38(2):133-43. PubMed ID: 19165648 [Abstract] [Full Text] [Related]
11. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. Chan FK, Hung LC, Suen BY, Wu JC, Lee KC, Leung VK, Hui AJ, To KF, Leung WK, Wong VW, Chung SC, Sung JJ. N Engl J Med; 2002 Dec 26; 347(26):2104-10. PubMed ID: 12501222 [Abstract] [Full Text] [Related]
12. Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis. Suárez-Otero R, Robles-San Román M, Jaimes-Hernández J, Oropeza-De La Madrid E, Medina-Peñaloza RM, Rosas-Ramos R, Castañeda-Hernández G. Proc West Pharmacol Soc; 2002 Dec 26; 45():26-8. PubMed ID: 12434517 [No Abstract] [Full Text] [Related]
13. Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac. White WB, Faich G, Whelton A, Maurath C, Ridge NJ, Verburg KM, Geis GS, Lefkowith JB. Am J Cardiol; 2002 Feb 15; 89(4):425-30. PubMed ID: 11835924 [Abstract] [Full Text] [Related]
14. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, Hubbard RC, Isakson PC, Verburg KM, Geis GS. Mayo Clin Proc; 1999 Nov 15; 74(11):1095-105. PubMed ID: 10560596 [Abstract] [Full Text] [Related]
15. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial. Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL. Lancet; 2010 Jul 17; 376(9736):173-9. PubMed ID: 20638563 [Abstract] [Full Text] [Related]
16. Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen. Whelton A, Lefkowith JL, West CR, Verburg KM. Kidney Int; 2006 Oct 17; 70(8):1495-502. PubMed ID: 16941030 [Abstract] [Full Text] [Related]
17. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Dougados M, Béhier JM, Jolchine I, Calin A, van der Heijde D, Olivieri I, Zeidler H, Herman H. Arthritis Rheum; 2001 Jan 17; 44(1):180-5. PubMed ID: 11212158 [Abstract] [Full Text] [Related]
18. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo. Sheldon E, Beaulieu A, Paster Z, Dutta D, Yu S, Sloan VS. Clin Ther; 2005 Jan 17; 27(1):64-77. PubMed ID: 15763607 [Abstract] [Full Text] [Related]
19. Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Clemett D, Goa KL. Drugs; 2000 Apr 17; 59(4):957-80. PubMed ID: 10804043 [Abstract] [Full Text] [Related]
20. Celecoxib versus diclofenac in the management of osteoarthritis of the knee. McKenna F, Borenstein D, Wendt H, Wallemark C, Lefkowith JB, Geis GS. Scand J Rheumatol; 2001 Apr 17; 30(1):11-8. PubMed ID: 11252686 [Abstract] [Full Text] [Related] Page: [Next] [New Search]